SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-016406
Filing Date
2021-04-20
Accepted
2021-04-20 16:49:58
Documents
1
Period of Report
2021-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4098
  Complete submission text file 0000899243-21-016406.txt   5511
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Issuer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Smith Brendan (Reporting) CIK: 0001857492 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38550 | Film No.: 21838510